Common Data Model
Connectivity alone is insufficient. To truly create value through collaboration, the cOS enables interoperability in a timely and accurate manner as patients and providers move across multiple care sites. Inherent to the data model is a hierarchy that enables intelligent sharing capabilities as illustrated in the following example:
It is this precisely this type of insight that helps improve quality of care, and is possible through the cross-referencing capability of the cOS data model to establish a "single source of the truth" without re-engineering the entire systems infrastructure.
Clinical Data Management
Clinical Data Managment (CDM) within the Net.Orange cOS™ is a secure decision support system to manage therapeutic programs of pharmaceutical and biotechnology companies. It is a HIPAA and FDA 21 CFR Part 11 compliant solution that was specifically designed to address the added requirements of a personalized therapeutics program and includes a rich data model to manage data related to proteomics, genomic expression, histology, pathway analyses and in vivo data. With the cOS, pharma and biotech companies can:
- Securely collaborate with business partners and electronically collect pre-clinical and clinical data such as gene expression results from business partners
- Compile data across various drug programs and compare trends
- Manage complex workflows that involve approvals, audits and reviews by multiple roles
- Perform sophisticated data analysis and mining functions to detect significant correlations such as between patient demographics and gene expression profiles
- Automatically interface protocols and electronic data collection (EDC) templates with clinical trial management solutions such as cOS Trials
